cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repligen Corp
25 own
9 watching
Current Price
$167.86
$-3.42
(-2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
9,772.61M
52-Week High
52-Week High
211.13000
52-Week Low
52-Week Low
110.45000
Average Volume
Average Volume
0.5M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
128.7606
iconMarket Capitalization9,772.61M
icon52-Week High211.13000
icon52-Week Low110.45000
iconAverage Volume0.5M
iconDividend Yield--
iconP/E Ratio128.7606
What does the Repligen Corp do?
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody-based therapeutics, recombinant proteins, and vaccines worldwide. It manufactures various forms of Protein A, a critical component used to purify antibody-based drugs. The company also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields. In addition, it manufactures and sells OPUS pre-packed chromatography columns, which are used in the purification of clinical-stage biologics; and tangential flow filtration cassettes that are used to concentrate clinical and commercial stage biologic drugs. Further, the company has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical companies, and contract manufacturers. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Repligen Corp make?
News & Events about Repligen Corp.
Fool.com Headlines
1 year ago
Investors appear to be anticipating an underwhelming first-quarter report from the bioprocessing company.Shares of bioprocessing technology company Repligen (NASDAQ: RGEN) were down by 10% on heavy volume as of 12:42 p.m. ET Tuesday. That steep decline appears to be connected to the first-quarter ...
Globe Newswire
1 year ago
Martin Madaus Repligen Appoints Martin Madaus to Board of Directors WALTHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences tools industry leader Martin D. Madaus. Dr. Madaus brings to the ...
Globe Newswire
1 year ago
Webcast and Conference Call to Be Held Wednesday, February 22, 2023 at 8:30 a.m. ESTWALTHAM, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2022 financial results on Wednesday, February 22, ...
Zolmax
1 year ago
Repligen (NASDAQ:RGEN Get Rating) had its price objective lowered by investment analysts at SVB Leerink from $230.00 to $200.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an outperform rating on the biotechnology companys stock. SVB ...
Globe Newswire
1 year ago
WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 41stAnnual J.P. Morgan Healthcare conference being held January 9-12 in San Francisco. Tony J. ...
Frequently Asked Questions
Frequently Asked Questions
What is Repligen Corp share price today?
plus_minus_icon
Can Indians buy Repligen Corp shares?
plus_minus_icon
How can I buy Repligen Corp shares from India?
plus_minus_icon
Can Fractional shares of Repligen Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Repligen Corp stocks?
plus_minus_icon
What is today’s traded volume of Repligen Corp?
plus_minus_icon
What is today’s market capitalisation of Repligen Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Repligen Corp?
plus_minus_icon
What percentage is Repligen Corp down from its 52-Week High?
plus_minus_icon
What percentage is Repligen Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$167.86
$-3.42
(-2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Penumbra Inc
Penumbra Inc
$206.15
$0.45 (0.22 %)
Blueprint Medicines Corp
Blueprint Medicines Corp
$92.26
$-0.03 (-0.03 %)
Glaukos Corp
Glaukos Corp
$100.93
$-0.17 (-0.17 %)
Haemonetics Corp
Haemonetics Corp
$86.22
$1.15 (1.35 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Penumbra Inc
Penumbra Inc
$206.15
$0.45 (0.22 %)
Blueprint Medicines Corp
Blueprint Medicines Corp
$92.26
$-0.03 (-0.03 %)
Glaukos Corp
Glaukos Corp
$100.93
$-0.17 (-0.17 %)
Haemonetics Corp
Haemonetics Corp
$86.22
$1.15 (1.35 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00